Effects of dipeptidyl peptidase 4 inhibitors on the risk of acute respiratory failure in patients with type 2 diabetes mellitus: a meta-analysis of cardiovascular outcomes trials

Effects of dipeptidyl peptidase 4 inhibitors on the risk of acute respiratory failure in patients with type 2 diabetes mellitus: a meta-analysis of cardiovascular outcomes trials

Dipeptidyl peptidase 4 (DPP-4) inhibitors are new antidiabetic drugs. Their effects on the respiratory system remain unclear. This study aimed to determine the association between DDP-4 inhibitors and acute respiratory failure (ARF) among patients with type 2 diabetes mellitus (T2DM). A meta-analysi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Wang, Caiyuan Yu, Xiaoyan Zheng, Yaya Wang, Wei Zhang
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-12-01
Series:Endocrine Journal
Subjects:
dipeptidyl peptidase 4 inhibitors
acute respiratory failure
type 2 diabetes mellitus
meta-analysis
cardiovascular outcomes trials
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/12/71_EJ24-0164/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items